Skip to main content
GoodMoatv1.3
Sign in
RARE logo

RARE

CompareEarnings: May 31, 2026

Ultragenyx Pharmaceutical Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

Did you know?

Capital expenditures decreased by 14% from FY24 to FY25.

Current Price

$24.77

+0.32%

GoodMoat Value

$28.14

13.6% undervalued
Profile
Valuation (TTM)
Market Cap$2.39B
P/E-4.16
EV—
P/B—
Shares Out96.48M
P/Sales3.55
Revenue$673.00M
EV/EBITDA—

Ultragenyx Pharmaceutical Inc (RARE) Company Profile

RARE Company Information

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases.

The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics.

Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

California, USA

RARE Key Officers

Key officers data coming soon

RARE Company Profile

Ultragenyx Pharmaceutical Inc (RARE) is a Healthcare company in the Biotechnology industry. It trades on NASDAQ. The company is based in California, USA.

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

Market cap is $2.39B. There are 96.5M shares outstanding.

See the full Ultragenyx Pharmaceutical Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if RARE is a good investment.